Asymmetric synthesis of (R)-N-3-butyn-2-yl-N-hydroxyurea, a key intermediate for 5-lipoxygenase inhibitors
- 31 March 1996
- journal article
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 7 (3) , 729-736
- https://doi.org/10.1016/0957-4166(96)00068-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Progress with investigational drugs for the treatment of pulmonary and inflammatory diseasesExpert Opinion on Investigational Drugs, 1994
- The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to AspirinAmerican Review of Respiratory Disease, 1993
- N,O-Bis(phenoxycarbonyl)hydroxylamine: a new reagent for the direct synthesis of substituted N-hydroxyureasThe Journal of Organic Chemistry, 1992
- The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry AirNew England Journal of Medicine, 1990
- Studies of NADP+-preferred secondary alcohol dehydrogenase from Thermoanaerobium brockiiBiochemistry and Cell Biology, 1990
- Asymmetric reductions with organoborane reagentsChemical Reviews, 1989
- Chemoenzymatic synthesis of chiral isoxazole derivativesThe Journal of Organic Chemistry, 1989
- The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural ProductsSynthesis, 1981
- Reduction of .alpha.,.beta.-acetylenic ketones with B-3-pinanyl-9-borabicyclo[3.3.1]nonane. High asymmetric induction in aliphatic systemsJournal of the American Chemical Society, 1980
- .alpha.-Methoxy-.alpha.-trifluoromethylphenylacetic acid, a versatile reagent for the determination of enantiomeric composition of alcohols and aminesThe Journal of Organic Chemistry, 1969